Acyclic
enediynes are generally inactive under physiological conditions
to be used as antitumor agents like their natural enediyne counterparts.
A new mechanism named as maleimide-assisted rearrangement and cycloaromatization
(MARACA) is uncovered to trigger the reactivity of acyclic enediynes.
Through this mechanism, cascade 1,3-proton transfer processes are
accelerated with the maleimide moiety at the ene position to enable
the acyclic enediynes to undergo cycloaromatization and generate reactive
radicals under physiological conditions. Computational studies suggest
that the highest energy barrier for MARACA is 26.0 kcal/mol, much
lower than that of Bergman cyclization pathway (39.6 kcal/mol). Experimental
results show that maleimide-based enediynes exhibit low onset temperature,
fast generation of radical species at 37 °C, and much faster
reaction in aqueous solution than in nonpolar solvent, which is beneficial
to achieve both high reactivity in physiological environment and high
stability for storage and delivery in nonpolar media. The generated
radical species are capable of causing high percentage of double-strand
(ds) DNA cleavage, leading to significant cytotoxicity toward a panel
of cancer cell lines with half inhibition concentration down to submicromolar
level. Overall, the discovery of the MARACA mechanism provides a platform
for designing novel acyclic enediynes with high potency for antitumor
applications.
Deciphering of the mycobiome in pristine karst caves has been impeded by constraints of remote locations, inaccessibility to specimens and technical limitations, which greatly restricted in-depth understanding of mycobiomes in subterranean ecosystem. Here, mycobiomes of Heshang Cave in south-western karst region of China were investigated by Illumina HiSeq sequencing of fungal rRNA-ITS1 gene across different habitats. In total 793,502 ITS1 reads and 2,179 OTUs from 778 Mb reads after stringent quality control (Q30) and 453 genera, 72 orders and 19 classes within 6 phyla were detected. Ascomycota (42% OTUs) dominated across the five habitats. Shannon-Wiener index varied from 1.25 to 7.62 and community richness was highest in drip waters, followed by weathered rocks, bat guanos, sediments, and air samples. Mycobiomes displayed specificity to five habitats and more distinct OTUs were found in weathered rocks (12%) and drip waters (9%). In contrast, only 6.60% core OTUs were shared by five habitats. Notably, weathered rocks possessed more indicator groups and were revealed for the first time to be dominated by Sordariomycetes (43%). The community richness of air mycobiomes increased from cave entrance to the innermost part and dominated by the indicator groups of Penicillium mallochii (>30%) and P. herquei (>9%). Our work represents the largest attempt to date to a systematical investigation of oligotrophic solution-cave-associated mycobiomes in China. Our discovery of high diversity of mycobiomes in Heshang Cave also suggests that eukaryotic microorganisms may play a crucial role in subsurface environments.
In general, the constant physicochemical conditions and limited nutrient sources over long periods in the subsurface support a stable ecosystem in karst cave. Previous studies on cave microbial ecology were mostly focused on community composition, diversity, and the relationship with local environmental factors.
Karst caves have recently been demonstrated to be a potential atmospheric methane sink, presumably due to consumption by methane-oxidizing bacteria. However, the sparse knowledge about the diversity, distribution, and community interactions of methanotrophs requires us to seek further understanding of the ecological significance of methane oxidation in these ecosystems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.